Yokohama, Japan - October 16, 2017 - New research found race and specific socioeconomic factors to have a significant influence on disparities in the survival rates of non-small cell lung cancer (NSCLC) patients. Dr. Yanyan Lou of the Mayo Clinic in the United States presented these findings today at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) in Yokohama, Japan.
While NSCLC patient outcomes have improved over time, the influence of race and socioeconomic factors on these outcomes has historically not been well studied. By using data from the National Cancer Database on NSCLC incident cases from 2004-2013 in the U.S., Dr. Lou and her team sought to determine whether a correlation exists between patients' overall survival (OS) and various socioeconomic factors and race.
Of the more than 1.1 million cases studied, 86.4 percent were White, 10.6 percent were Black, and smaller proportions were Asian and Hispanic. Income was fairly evenly distributed. Additionally, a majority of the cases were individuals who were insured, lived in a metro area and received care at non-academic facilities.
The researchers found that the median overall survival was significantly better for Asians and Hispanics as compared to Whites and Blacks. The range of medians between the highest (Asians) and lowest (Blacks) OS rates was over half a year (6.7 months). Additionally, they found that outcomes were worse when there was a higher rate of comorbidity with other diseases, advanced stage and treatment at a community or low-volume center. Finally, the researchers determined that specific socioeconomic factors were associated with worse outcomes, including lower education levels, lower median income and uninsured status.
Based on this study, the researchers determined that the influence of race and specific socioeconomic factors is significant. In order to ensure fair treatment and patient outcomes, these factors must be considered in the provision of care for NSCLC.
"The study is the largest analysis on the correlation between race and socioeconomic factors and NSCLC outcomes to date," said Dr. Lou. "Our findings indicate that improving outcomes for NSCLC patients doesn't solely rely on advancements in medicine, but also on ensuring more equitable health care delivery."
About the WCLC
The World Conference on Lung Cancer (WCLC) is the world's largest meeting dedicated to lung cancer and other thoracic malignancies, attracting over 6,000 researchers, physicians and specialists from more than 100 countries. The goal is to disseminate the latest scientific achievements; increase awareness, collaboration and understanding of lung cancer; and to help participants implement the latest developments across the globe. Organized under the theme of "Synergy to Conquer Lung Cancer," the conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit http://wclc2017.
About the IASLC
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit http://www.